Obermatt
See Similar Stocks →

Flags

Financial distress

AVITA Medical

NAQ:RCEL · US05380C1027
BiotechnologyX-Small

360

31
Profit price63
Owner Earnings Yield1
Dividend Yield1
Price/Sales59
EV / Gross Profit65
Price/Book93
Return on Capital22
Cash Return on Capital8
EBIT Margin44
Gross Profitability100
Accruals70
Owner Earnings Margin66
Sales growth68
Profit growth10
Reinvestment82
Price momentum38
Debt load1
Refinancing52
Debt Payback1
Liquidity22
Analyst ratings69
Opinion Changes10
Price Target Upside20
Market mood53
Value Creation2/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

AVITA Medical doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQCM
Employees185
Websiteavitamedical.com
ISINUS05380C1027
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Health DiagnosticsOrthopaedicsSurgeryDermatologyBiomedical EngineeringBiotechnologyHealth CareMedical Device

Description

AVITA Medical, Inc. (AVITA Medical) is a therapeutic acute wound care company delivering transformative solutions. The company's designed technologies to optimize wound healing, accelerate patient recovery, and improve clinical and economic outcomes…

Analysis

Middle-of-the-road

AVITA Medical, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 2/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
33
2026

All-time high

56

Mar 2026

All-time low

33

Jun 2026

Average rank

45

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
59
—
—
—
Price/Earnings
82
—
—
—
Price/Book
93
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
80
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare AVITA Medical with its peers
Helios Technologies
NYQ:HLIO
48
CountryUSA
IndustryMachinery
SizeMedium
Full Stock Analysis →
Carlsmed
NSQ:CARL
29
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
American Well
NYQ:AMWL
36
CountryUSA
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →
eGain
NAQ:EGAN
88
CountryUSA
IndustrySoftware
SizeSmall
Full Stock Analysis →
McKesson
NYQ:MCK
83
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Phreesia
NYQ:PHR
70
CountryUSA
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →